PEG-MGF Is a Tag on a Peptide a 2010 Review Said Nobody Had Isolated

01What it is

Insulin like growth factor 1 is the growth signal the liver releases when growth hormone reaches it, and the mature protein is 70 amino acids. Mechano growth factor is not a second molecule but a spliced message from the IGF-1 gene, spliced meaning the cell cuts and rejoins a transcript, the working copy of the gene the cell reads, so one gene yields more than one product.

An extra 49 bases land in exon 5, one of the coding blocks of the gene, and shift the reading frame, the three letter grouping the cell reads the code in. So the prohormone, the long uncut version of the protein, ends in a different string of amino acids from the one systemic IGF-1 carries. The vial holds the last 24 of them, synthesised: YQPPSTNKNTKSQRRKGSTFEERK (PMID 24908137). Check it yourself against UniProt entry P05019, the reference record for human IGF-1: those are exactly the last 24 residues of its isoform 4, and they weigh about 2,868 daltons. It is the offcut left when the mature protein is cleaved away, and contains none of it (PMID 24253050). PEG-MGF is that offcut with polyethylene glycol on it, an inert polymer that makes a molecule bigger so the kidney clears it slower, attachable at five amine sites on those 24 residues.

The part that undoes the chain: the 2010 Endocrinology review recorded that no such peptide had been isolated from cells, medium, animal tissue or fluid, that no evidence shows the transcript makes a stable one, and that no receptor has been found (PMID 20130113).

02What the trials found

I could not find one, and that is the entry.

A PubMed search for PEG-MGF and its variants returns seven records, none a study of this compound. An intervention search on the United States registry returns zero and the European register nothing. I found no published study in which PEG-MGF, or MGF in any form, was given to a human being, and FDA says the same on its compounding page: it has identified no human exposure data on PEG-MGF products by any route. The only peer-reviewed paper I found that treats PEG-MGF as a compound rather than as a string of letters records its human evidence as none, and says no published clinical study has even reported the route people take it by (PMID 42395176).

The cell work is where the compound was born and came apart. Yang and Goldspink reported in 2002 that the E domain made cultured immature muscle cells divide more and mature less, through something other than the IGF-1 receptor (PMID 12095637). Twelve years later Fornaro and colleagues, at two pharmaceutical companies, could not reproduce it: up to 500 ng/ml did nothing to proliferation or differentiation in mouse C2C12 cells, human muscle myoblasts or primary mouse muscle stem cells, while mature IGF-1 and full length IGF-1Eb worked in the same hands (PMID 24253050). Neither of the two circulating versions of the 24 amino acid peptide switched on the human IGF-1 receptor in a dish, while the whole prohormone did (PMID 26991004).

The live animal record is all unpegylated peptide, and almost none of it muscle: a bone defect in 27 rabbits (PMID 21057789), 35 percent less compromised heart muscle than controls at eight days in sheep given heart attacks by injected microspheres, at 200 nanomolar and no animal counts given (PMID 17581790), and mice living longer after a heart attack when the peptide seeped out of implanted polymer rods, assessed out to 10 weeks, the polyethylene glycol there a scaffold, not a tag (PMID 25678113). The one study I found that tested muscle repair itself injected the peptide into bruised muscle in mice whose macrophages had been stripped out, the immune cells that clear debris from damaged muscle, and found no protection of fibre regeneration, though scarring fell (PMID 31164836). The authors' own reading is the softer one: their title says the regeneration failure caused by removing those cells could be partly ameliorated by the injection.

03The 25 percent, and the document it points to

The sales pages I opened all carry the same number: a 25 percent increase in muscle fibre cross-sectional area in two weeks. Goldspink states it himself, in Physiology News in 2003: injection into muscle of MGF cDNA in a plasmid vector, a loop of DNA that makes the muscle manufacture the product itself, produced that increase. His sentence names no species, so the animal it happened in is not on the record either. A gene, not a peptide, and certainly not a pegylated one.

The citation attached to that sentence, in the article's own reference list, is Goldspink G (2001), Method of treating muscular disorders, United States Patent No. US 6,221,842 B1. I searched the full description: no 25 percent figure, no cross-sectional area measurement, no plasmid, no mice. Nor could I find the experiment in a peer-reviewed paper.

The next sentence is the one it gets confused with: similar work with liver IGF-IEa cDNA, which Goldspink calls viral constructs, gave a 25 percent increase in muscle mass over four months. That is Goldspink's account of it. The paper he cites, Musaro and colleagues in Nature Genetics (PMID 11175789), is real, but what they built was a mouse bred with the gene already installed in its muscle, not a virus delivering anything, and neither the 25 percent nor the four months appears in their abstract.

04How it compares

Injecting a gene and injecting a peptide are different operations, the way installing a boiler and carrying in a bucket of hot water are. One of them keeps producing. And most of what I sampled is neither: a PubMed search returns 205 records, and the ones I opened mostly measure messenger RNA rather than giving the peptide to anything.

05Where the dose came from

The protocol that circulates was compiled in that 2026 review from bodybuilding forums its authors call often internally inconsistent. Their row for PEG-MGF, reported here as convention and not as a tested schedule, runs 200 to 400 micrograms two to three times a week under the skin or into a muscle after training, cycles of 8 to 16 weeks, then a maintenance figure of 200 to 400 micrograms per day. Twice weekly and daily, in one row, disagreeing.

For an 80 kg adult that is 2.5 to 5 micrograms per kilogram. The rabbit study used 28.5 and 57, only the 57 separated from no treatment, and it went into a surgical bone defect, not muscle or fat. Against the dose that worked, the circulating amount is 11 to 23 times smaller per kilogram.

Then the half-life, the whole selling proposition and the part I could not source. What circulates is about 5 to 7 minutes for native MGF against 48 to 72 hours once pegylated, and the two figures do not come off the same page. One vendor page prints the 48 to 72 hours. A second prints several hours to days against 5 to 7 minutes, and says on that same page that no human data on how the compound moves through the body exists and that the right dose for any use is unknown. Neither figure traces to a measurement I could find in any species, and the review records the half-life as not reported.

06What could go wrong

There is no human safety record to report, because I found no study of it in a person.

The cancer signal is on this exact fragment. Armakolas and colleagues found the IGF-1Ec isoform in prostate cancer biopsies, expression tracking tumour stage, and cells engineered to overexpress the Ec peptide proliferated more, took on the migratory state that precedes metastasis, and seeded more tumours in mice (PMID 25569803). The same Athens laboratory later raised proliferation of an oestrogen responsive human breast cancer line, though not a hormone resistant one, by adding the synthetic peptide from outside (PMID 28551627). Shared authors, so not replication, and the prostate work is overexpression rather than injection.

What is in the vial is unsettled twice over. Two anti-doping laboratories opened black market MGF and found an altered molecule, the terminal lysine gone and an arginine swapped for a histidine, counted on the 24 amino acid peptide as R23H (PMID 25466910, PMID 28035768). And a vendor specifies PEG-MGF at approximately 2867.2 g/mol, qualified as the core peptide and varying with PEG size, with the formula C121H200N42O39, which is that same peptide capped as an amide, against 2,868 for the peptide the gene encodes. No polymer in the number, no chain length, count or attachment site. The tag is in the name and nowhere in the spec.

Mechano growth factors sit at section S2.3 of the World Anti-Doping Agency's 2026 Prohibited List, whose class header reaches substances of similar structure or effect, prohibited at all times and since 2005 (PMID 25466910). In September 2023 FDA put it in the category for substances it has identified significant safety risks with. It has since come off that list, filed under substances withdrawn by their nominators rather than cleared.

07What no one seems to know

Whether the peptide exists as a molecule in a living animal. Nothing published since 2010 that I found reports isolating one, and I found no third attempt at the founding cell result to settle it.

What is in a vial: native sequence or R23H, what polymer, at what size, at which amine site, how many chains. And how either form moves through a body.

08The honest read

The 25 percent is the harder problem, not the missing trials. A missing trial is an absence, and absences are honest. That figure is specific, it is on every sales page I opened, and its originator cites it to a patent that does not contain it.

If you want to check the load-bearing part of this yourself, pull up United States Patent 6,221,842 B1 on Google Patents and search its description for 25%. I got no hits. And if you have bought PEG-MGF, I want to know what molecular weight its certificate of analysis gave, and whether anything on it mentioned the polyethylene glycol at all.

Frequently asked

Has PEG-MGF ever been tested in people?+

Not in the published record that I could reach. I found no study in which PEG-MGF was given to a human being, no registration on the United States or European trial registers, and no study in which mechano growth factor in any form was given to a human being. FDA states on its own compounding page that it has not identified any human exposure data on drug products containing PEG-MGF administered via any route of administration.

What is the difference between IGF-1, MGF and PEG-MGF?+

Insulin like growth factor 1 is the growth signal the liver puts out when growth hormone reaches it, and the mature circulating protein is 70 amino acids long. Mechano growth factor is not a separate molecule with its own gene, it is a name for an alternatively spliced message from that same gene, called IGF-IEb in rodents and IGF-IEc in humans. The peptide sold as MGF is the last 24 amino acids of the tail that message produces, which is the offcut left after the mature IGF-1 protein is cleaved away and does not contain it. PEG-MGF is that 24 amino acid peptide with a polyethylene glycol chain attached to slow its clearance.

Where does the 25 percent muscle growth figure come from?+

From a 2003 article by Goldspink in Physiology News describing intramuscular injection of MGF cDNA in a plasmid vector, which is gene transfer rather than a peptide injection, producing a 25 percent increase in muscle fibre cross-sectional area in two weeks. His sentence names no species. The only source cited for it is his own United States patent 6,221,842 B1. I read that patent's full description and it contains no 25 percent figure, no cross-sectional area measurement, no plasmid and no mice, and I could not find the experiment reported in a peer-reviewed paper.

What dose do people use, and where did that number come from?+

A 2026 review compiled the circulating protocol from bodybuilding forums and industry sources and labelled it convention rather than a tested schedule: 200 to 400 micrograms two to three times a week under the skin or into a muscle after training, cycles of 8 to 16 weeks, and a maintenance figure of 200 to 400 micrograms per day sitting in the same row and contradicting the twice weekly one. Those figures are reported here as what circulates, not as a recommendation. I found no derivation for any of it, no dose ranging work and no study in any species measuring how it moves through the body.

Is PEG-MGF banned in sport?+

It is covered. Mechano growth factors appear at section S2.3 of the World Anti-Doping Agency's 2026 Prohibited List, in a class whose header extends to other substances of similar chemical structure or similar biological effect, and everything in that class is prohibited at all times, in and out of competition. Mechano growth factor has been prohibited since 2005.

Is PEG-MGF safe?+

There is no human safety record to report, because I found no study in which it was given to a person. Two things sit around that gap. The same 24 amino acid fragment has been studied in cancer biology, where prostate cancer cells engineered to overexpress it proliferated and spread more in mice, and the synthetic peptide increased proliferation of one human breast cancer cell line in a dish. And two anti-doping laboratories opening black market MGF found an altered sequence rather than the native one.

---

This content is for educational and informational purposes only and is not medical advice. Peptides discussed are research compounds and may not be approved for human use. Nothing here should be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any peptide, supplement, or protocol. Individual responses vary. Do not self-administer compounds without proper medical supervision.